Herbal products including Bacopa monnieri, Crocus sativus, Ginkgo biloba, Hypericum perforatum, Lavandula angustifolia, Melissa officinalis, Panax ginseng, Passiflora incarnata, Pinus pinaster, Valeriana officinalis, and Withania somnifera show clinical promise for mental health symptoms in children and adolescents.
A systematic review of 29 clinical trials identified 11 herbal products with clinical promise for pediatric mental health conditions including ADHD, anxiety, depression, nervous agitation, restlessness, and sleep disturbances. The review highlights both potential benefits and current limitations, emphasizing the need for standardized preparations and clinical oversight.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Herbal products including Bacopa monnieri, Crocus sativus, Ginkgo biloba, Hypericum perforatum, Lavandula angustifolia, Melissa officinalis, Panax ginseng, Passiflora incarnata, Pinus pinaster, Valeriana officinalis, and Withania somnifera show clinical promise for mental health symptoms in children and adolescents. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Herbal products including Bacopa monnieri, Crocus sativus, Ginkgo biloba, Hypericum perforatum, Lavandula angustifolia, Melissa officinalis, Panax ginseng, Passiflora incarnata, Pinus pinaster, Valeriana officinalis, and Withania somnifera show clinical promise for mental health symptoms in children and adolescents.
This conclusion is most relevant to: Children and adolescents with mental health symptoms (including pathological conditions and borderline symptoms).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Medicinal Plants for Child Mental Health: Clinical Insights, Active Compounds, and Perspectives for Rational Use. (Children (Basel, Switzerland), 2025) —
How It Works
The proposed biological pathway:
- ▸Herbal compounds interact with multiple molecular targets
- ▸Bioinformatic predictions reveal polypharmacological activity
- ▸Pathways involve neuroinflammatory, neuroprotective, and neurotransmitter-related mechanisms
- ▸Result: Potential therapeutic effects on pediatric mental health symptoms
Who Might Benefit
Evidence fit by population:
- ▸Children and adolescents with mental health symptoms (including pathological conditions and borderline symptoms)
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Limited number of clinical trials (29 total) with varying quality and design
- ▸Lack of specific dosing, safety, and integrative care strategy data for pediatric populations
Frequently Asked Questions
Which herbal products showed clinical promise for child mental health?▼
Eleven herbal products were identified: Bacopa monnieri, Crocus sativus, Ginkgo biloba, Hypericum perforatum, Lavandula angustifolia, Melissa officinalis, Panax ginseng, Passiflora incarnata, Pinus pinaster, Valeriana officinalis, and Withania somnifera.
What conditions were studied in the clinical trials?▼
The trials covered pathological conditions like ADHD, anxiety, and depression, as well as borderline symptoms such as nervous agitation, restlessness, and sleep disturbances.
What are the main limitations of using herbal products for pediatric mental health?▼
The review highlights limited clinical trial evidence, lack of standardized dosing and safety data for children, and the need for clinical oversight and further research.
What mechanisms might explain the effects of these herbal products?▼
Bioinformatic analyses suggest polypharmacological activity involving neuroinflammatory, neuroprotective, and neurotransmitter-related pathways.
References
- 1.Rigillo G, Blom JMC, Cocchi A, Martinucci V, Favaro F, Baini G, Cappellucci G, Tascedda F, Biagi M. “Medicinal Plants for Child Mental Health: Clinical Insights, Active Compounds, and Perspectives for Rational Use..” Children (Basel, Switzerland), 2025. PMID: 41007011 DOI: 10.3390/children12091142